Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
21,198,794
-
Shares change
-
+21,018,388
-
Total reported value, excl. options
-
$97,089,813
-
Value change
-
+$96,755,410
-
Number of buys
-
25
-
Number of sells
-
5
-
Price
-
$4.58
Institutional Holders of Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN) as of Q3 2025
As of 30 Sep 2025 Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN) had 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 21,198,794 shares of stock of the company.
Largest 10 holders included Pantera Capital Partners LP, Ikarian Capital, LLC, VANGUARD GROUP INC, HRT FINANCIAL LP, GEODE CAPITAL MANAGEMENT, LLC, BOOTHBAY FUND MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, BIT Capital GmbH, CITADEL ADVISORS LLC, and Virtu Financial LLC.
This table shows 31 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.